| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 46.637 | 239.393 | 361.236 | 930.890 | 853.213 | 830.894 | 391.626 |
| Total Income - EUR | - | - | - | 46.651 | 239.470 | 361.237 | 930.898 | 854.090 | 831.320 | 392.550 |
| Total Expenses - EUR | - | - | - | 3.306 | 92.102 | 194.124 | 849.964 | 841.637 | 667.276 | 291.569 |
| Gross Profit/Loss - EUR | - | - | - | 43.346 | 147.368 | 167.113 | 80.935 | 12.453 | 164.044 | 100.981 |
| Net Profit/Loss - EUR | - | - | - | 41.946 | 144.973 | 163.501 | 72.742 | 4.092 | 150.604 | 77.447 |
| Employees | - | - | - | 0 | 3 | 3 | 2 | 2 | 5 | 2 |
Check the financial reports for the company - Expert Pharma Construct S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 24 | 425 | 1.895 | 70.890 | 61.133 | 37.683 | 7.385 |
| Current Assets | - | - | - | 51.960 | 230.707 | 434.489 | 511.776 | 232.138 | 190.260 | 64.296 |
| Inventories | - | - | - | 0 | 0 | 6.406 | 81.578 | 146.639 | 54.527 | 0 |
| Receivables | - | - | - | 33.042 | 123.014 | 258.388 | 88.468 | 60.737 | 56.680 | 55.500 |
| Cash | - | - | - | 18.918 | 107.693 | 169.695 | 341.730 | 24.762 | 79.053 | 8.796 |
| Shareholders Funds | - | - | - | 41.989 | 186.149 | 321.208 | 387.192 | 4.140 | 153.623 | 23.378 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 9.995 | 44.983 | 116.498 | 195.474 | 289.253 | 74.320 | 48.303 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4322 - 4322" | |||||||||
| CAEN Financial Year |
4322
|
|||||||||
Comments - Expert Pharma Construct S.r.l.